Literature DB >> 28461870

Assessment of refractive outcome of femtosecond-assisted LASIK for hyperopia correction.

Mohamed Tarek El-Naggar1, Dikran Gilbert Hovaghimian1.   

Abstract

INTRODUCTION: Laser vision correction for hyperopia is challenging. The purpose of the study was to assess the refractive outcomes of femtosecond-assisted laser in situ keratomileusis (LASIK) for hyperopic correction using wavefront-optimized ablation profiles.
METHODS: This retrospective case series study included 20 Egyptian patients (40 eyes) with hyperopia or hyperopic astigmatism with a mean manifest refraction spherical equivalent (MRSE) of +2.55D±1.17 (range from +1.00 to +6.00) who had uneventful femtosecond-a assisted LASIK with wavefront-optimized aspheric ablation profile using refractive surgery suite (WaveLight FS200 Femtosecond Laser and WaveLight EX500 Excimer Laser) performed in the Research Institute of Ophthalmology and International Eye Hospital, Giza, Egypt. Statistical analysis was done using Microsoft Excel (Microsoft Corporation, Seattle, WA, USA).
RESULTS: The procedure significantly reduced the MRSE and cylinder post-operatively (95% were ± 0.50D and 100% ± 1.00 D), with stability of refraction and UDVA over the follow-up period (up to 12 months) after surgery. No eye lost any line of the CDVA, which reflects the excellent safety profile of the procedure; on the other hand, one eye (5%) gained one line and one eye (5%) even gained two lines. There were no significant complications during the procedure.
CONCLUSIONS: Femtosecond-assisted laser in situ keratomileusis for hyperopia showed predictable, effective, and safe refractive outcomes that were stable through 12 months. Longer follow-up period is required to detect any further regression.

Entities:  

Keywords:  Femtosecond LASIK; Hyperopia correction; Refractive outcomes; Refractive surgery

Year:  2017        PMID: 28461870      PMCID: PMC5407228          DOI: 10.19082/3958

Source DB:  PubMed          Journal:  Electron Physician        ISSN: 2008-5842


1. Introduction

Hyperopic laser vision correction is considered challenging for refractive surgeons (1, 2). Although LASIK is considered by many refractive surgeons as the preferred technique, hyperopic correction presents additional challenges, starting from accurate detection of patient manifest refraction and integration of the cycloplegic refraction in this process followed by accurate centeration (1–9). Basically, the aim of excimer laser photo ablation in the case of hyperopic correction is to induce relative steepening in the central part of the cornea; this target is achieved by an annular ablation profile, which induces more flattening in the corneal periphery; thus, it is considered more challenging than the myopic ablation, which induces direct flattening in the corneal central area (1, 3). Another difficulty is that hyperopic correction ablation time is longer than the equivalent dioptric correction for myopic refraction, which makes it more sensitive to patient eye movement and requires an accurate and fast eye-tracker in order to ensure that you place your laser ablation in the planned location (2); this problem may be further complicated by the fact that most of the patient who are seeking hyperopic refractive surgery are relatively old, so they may have a problem in fixation to a near target during ablation due to the presbyopic element, which may lead to de-centeration of the ablation. This problem is largely overcome by the newer, accurate eye-trackers combined with faster excimer laser systems (10, 11). Another dilemma is where to center the ablation profile: the corneal vertex, the pupil center, or somewhere in between in order to estimate the true visual axis; the problem is even exaggerated in these patients, as they usually have a wider-angle Kappa (10, 11). Higher incidence of epithelial ingrowth as the ablation occurs in the periphery adjacent to the flap edge so the epithelium might find a way under the flap to the deep ablated zone (12). Greater tendency of regression has been reported (5, 13), which may be explained by postoperative loss of accommodative spasm, mechanical instability of corneal tissue biomechanics, and/or irregular epithelial remodeling over the ablation zone (13). Several advancements in hyperopic LASIK technique have been applied to overcome some of the previously mentioned problems, including a larger optical zone, which requires larger flap making, nomogram refinement, and proper centration (13). In our study, we assessed the refractive outcomes of femtosecond assisted hyperopic LASIK performed for the correction of low to moderate hyperopia.

2. Material and Methods

2.1. Setting and study design

This retrospective study comprised 20 Egyptian patients (12 females and eight males) who had femtosecond laser-assisted hyperopic LASIK using refractive surgery suite (WaveLight FS200 Femtosecond Laser and WaveLight EX500 Excimer Laser; Alcon Laboratories, Ft Worth, TX, USA), between January 2012 and September 2013 in the Research Institute of Ophthalmology and International Eye Hospital, Giza, Egypt. The mean age of the patients was 47.2±3.84 (ranging from 42 to 56 years); all treatments were performed by the same surgeon (T.N).

2.2. Selection criteria

Inclusion criteria included a postoperative follow-up of at least 12 months and preoperative stable refraction for at least one year, normal corneal tomography with expected postoperative steep K reading not more than 48D, and postoperative residual stromal bed not less than 300 μm. Exclusion criteria included a preoperative CDVA of worse than 20/30, previous ocular surgeries, and corneal, uveal or retinal diseases. Amblyopic patients and glaucoma patients were also excluded.

2.3. Preoperative examination and follow-up

The preoperative examination included measuring uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest and cycloplegic refractions; full ophthalmological examination included slitlamp biomicroscopy, Goldmann applanation tonometry, and full fundus evaluation. Corneal tomography with placido-based topolyzer vario topography (WaveLight, Erlangen, Germany) and Scheimpflug-based imaging system (Pentacam, Oculus Optikgeräte GmbH) were also performed in all cases. Postoperative follow-up examinations were conducted at 1 day, 1 week, 1 month, 3 months, 6 months, and 1 year.

2.4. Surgical technique

Prior to the surgery, topical benoxinate hydrochloride 0.4% was instilled into the eyes. A lid speculum was used to open the eyelid. Femtosecond flap creation with a WaveLight FS200 femtosecond laser system was performed with intended flap diameter of 9.3 mm to allow a large ablation zone and transitional zone, an attempted flap thickness of 120 μm with superior hinge and side angle cut of 120 degrees. Excimer laser photo ablation was performed after lifting the femtosecond created flap using a WaveLight EX500 excimer laser system with an optical zone of 7 mm. The treatment was centered on the corneal vertex when the difference between the pupil centroid and corneal vertex was less than 0.30 mm, which was measured by the topolyzer vario topography (WaveLight, Erlangen, Germany).

2.5. Ethics

This study was approved by the Institutional Review Board and adhered to the tenets of the Declaration of Helsinki.

2.6. Analyses

Statistical analysis and graphs were done with standard spreadsheet software program using Microsoft Excel 2013 (Microsoft Corporation, Seattle, WA, USA).

3. Results

To assess the refractive outcome of the procedure, UDVA, CDVA, MRSE, manifest refractive cylinder, and stability were compared preoperatively and 1 week and 1, 3, 6, and 12 months postoperatively. Following the recommendation of Waring et al. for standardized graphs and terms for refractive surgery results, the data were plotted in set of six standard graphs summarizing efficacy, predictability, safety, refractive astigmatism, and stability using Microsoft Excel templates (Microsoft Corporation, Seattle, WA, USA) designed by London Vision Clinic (London, W1G 7LA, UK). Regarding the efficacy, as shown in Figure 1, the preoperative CDVA compared with 12 months’ postoperative UDVA showed that all the 20 eyes (100%) reached UDVA of 20/25 or better, and 17 eyes (85%) reached 20/20 of UDVA, which reflected excellent efficacy of the procedure. In Figure 2 preoperative and postoperative CDVA were analyzed, and the visual acuity lines gain and loss were plotted showing that no eye lost any line of the CDVA, which reflected excellent safety of the procedure; on the other hand, one eye (5%) gained one line and one eye (5%) even gained two lines; these results reflect potential extra benefits of the procedure and might be explained by the correction made on the corneal level, which is optically better than that on the glasses level and might be related to aberrations induced by the hyperopic magnifying plus lens used to correct hyperopia.
Figure 1

Preoperative CDVA (RED) compared with 12 months’ postoperative UDVA

Figure 2

The change of the CDVA 12 months postoperatively

Predictability and refractive accuracy: Predictability was directly associated with a lower standard deviation (SD) and standard error of the SE deviation from the target at any point and a better tightness of fit of the attempted SE versus the achieved SE plot (reflected by the correlation coefficient R2 = 0.947). The procedure showed good predictability, as shown in Figure 3. The scattergram comparing the achieved spherical equivalent refraction versus the attempted spherical equivalent refraction of every eye showed that all the eyes were within +/−1.00 D postoperatively, and 95% (19 eyes) were within +/−0.50 D 12 months postoperatively. Further assessment of the refractive accuracy was analyzed; Figure 4 shows the exact distribution of the 12 months’ postoperative UDVA in the whole series.
Figure 3

Scattergram comparing achieved spherical equivalent refraction 12 months’ postoperatively (Y axis) and attempted spherical equivalent refraction (X axis)

Figure 4

Refractive accuracy expressed in postoperative spherical equivalent

Figure 5 shows a comparison between the preoperative refractive astigmatism and 12 months’ postoperative refractive astigmatism, 85% of the eyes (17 eyes) had less than or equal to 1D of astigmatism 12 months postoperatively, and 30% (six eyes) had less than or equal to 0.5 D astigmatism 12 months postoperatively. Stability was defined as the repeatability of first week postoperative spherical equivalent refraction over the 12 months of follow-up. Figure 6 shows the stability curve over the 12 months’ follow-up period which was excellent.
Figure 5

Twelve months’ postoperative astigmatism (blue) compared to preoperative astigmatism (red)

Figure 6

Stability over 12 months’ follow-up

4. Discussion and conclusions

As previous studies reported better refractive results with femtosecond laser flap creation than with mechanical microkeratome flap creation (14, 15), the purpose of this study was to evaluate the refractive outcome of femtosecond-assisted LASIK for the correction of hyperopia using the Alcon-WaveLight FS200 femtosecond laser system and the Allegreto EX500 as using a femtosecond laser in flap creation has potential benefits, as it creates a smoother stromal bed under the created flap, which is assumed to yield better refractive outcomes after laser refractive surgery (14–25). In this study, a flap creation as large as 9.3 mm was intended to allow accurate placement of the peripheral laser ablation inside the stromal bed and avoid hitting the peripheral epithelium, which eventually will regenerate with no refractive effect, leading to a more accurate and potentially more stable ablation. A planar flap results in less cutting of peripheral stromal fibers (14–25). In addition, the stroma bed is relatively dry after flap lifting, which may improve the efficacy of laser ablation, resulting in more optimal refractive outcome of hyperopia correction (14, 15, 24). Further, strong adhesion of the flap in the postoperative period may produce a stronger biomechanical flap stability (20). Several studies (3–9, 13, 15, 26–32) reported the outcome of excimer laser photoablation to correct hyperopia with different platforms with variable follow-up periods. These studies showed a high safety profile of the procedure with good efficacy and predictability except in high hyperopic correction (13). It should be noted that evaluating refractive outcomes after hyperopic LASIK can be challenging, as some patients may still have some sort of accommodation power, and some of them did not wear glasses for distance and acquired some sort of accommodative spasm, which takes time to relax. Another important factor is that assessing refractive stability could be difficult because manifest refraction in hyperopic eyes can increase with age due to reduced ability to compensate for latent hyperopia, which could be falsely interpreted as regression of the procedure outcome. In our study, femtosecond-assisted LASIK appears to be safe, predictable, and effective in correcting eyes with hyperopia in the first week, and the results remain almost stable within the follow-up period (12 months). The small sample size might be a limiting factor in our study, and longer follow-up is needed for a better conclusion regarding stability of the procedure.
  32 in total

1.  Factors that influence outcomes of hyperopic laser in situ keratomileusis.

Authors:  Rosario Cobo-Soriano; Fernando Llovet; Félix González-López; Blanca Domingo; Fernando Gómez-Sanz; Julio Baviera
Journal:  J Cataract Refract Surg       Date:  2002-09       Impact factor: 3.351

2.  Femtosecond laser-assisted corneal flap cuts: morphology, accuracy, and histopathology.

Authors:  Mike P Holzer; Tanja M Rabsilber; Gerd U Auffarth
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

3.  Comparative study of stromal bed of LASIK flaps created with femtosecond lasers (IntraLase FS150, WaveLight FS200) and mechanical microkeratome.

Authors:  George D Kymionis; Georgios A Kontadakis; Irini Naoumidi; Vardhaman P Kankariya; Sophia Panagopoulou; Alexandra Manousaki; Michael A Grentzelos; Ioannis G Pallikaris
Journal:  Br J Ophthalmol       Date:  2013-11-01       Impact factor: 4.638

4.  One-year results of excimer laser in situ keratomileusis for hyperopia.

Authors:  Fernando Llovet; Ahmed Galal; Jose-Manuel Benitez-del-Castillo; Julio Ortega; Clara Martin; Julio Baviera
Journal:  J Cataract Refract Surg       Date:  2009-07       Impact factor: 3.351

Review 5.  LASIK for correction of hyperopia and hyperopia with astigmatism.

Authors:  E Suarez; F Torres; M Duplessie
Journal:  Int Ophthalmol Clin       Date:  1996

6.  Corneal hydration affects ablation during laser in situ keratomileusis surgery.

Authors:  W S Kim; J M Jo
Journal:  Cornea       Date:  2001-05       Impact factor: 2.651

7.  Long-term evaluation of hyperopic laser in situ keratomileusis.

Authors:  David Zadok; Frederick Raifkup; David Landau; Joseph Frucht-Pery
Journal:  J Cataract Refract Surg       Date:  2003-11       Impact factor: 3.351

8.  Hyperopic LASIK with Esiris/Schwind technology.

Authors:  Jorge Alió; Ahmed Galal; Maria José Ayala; Alberto Artola
Journal:  J Refract Surg       Date:  2006-10       Impact factor: 3.573

9.  Photorefractive keratectomy and LASIK for the correction of hyperopia: 2-year follow-up.

Authors:  Leopoldo Spadea; Lelio Sabetti; Laura D'Alessandri; Emilio Balestrazzi
Journal:  J Refract Surg       Date:  2006-02       Impact factor: 3.573

10.  Five techniques for improving outcomes of hyperopic LASIK.

Authors:  Roberto Zaldivar; Susana Oscherow; Harkaran S Bains
Journal:  J Refract Surg       Date:  2005 Sep-Oct       Impact factor: 3.573

View more
  4 in total

1.  One-year follow-up of patients with hyperopia undergoing photorefractive keratectomy with Allegretto WaveLight Eye Q 400.

Authors:  Behrad Shahin; Habib Ojaghi; Firouz Amani
Journal:  J Med Life       Date:  2022-04

2.  Patient satisfaction and self-reported dry eye symptoms in hyperopic patients treated with femtosecond laser in situ keratomileusis.

Authors:  Petri Mäkinen; Anne Huhtala; Juhani Pietilä; Janika Nättinen; Teppo Rajala; Kalle Salmenhaara; Magomed Udratov; Hannu Uusitalo
Journal:  Clin Ophthalmol       Date:  2019-04-26

3.  Femtosecond-LASIK outcomes using the VisuMax®-MEL® 80 platform for hyperopia and hyperopic astigmatism refractive surgery.

Authors:  Bogdana Tăbăcaru; Horia Tudor Stanca; Ruxandra Angela Pîrvulescu; Simona Stanca; Ciprian Danielescu; Mihnea Munteanu; Cosmin Roșca; Adrian Cosmin Teodoru
Journal:  Exp Ther Med       Date:  2021-01-26       Impact factor: 2.447

Review 4.  Future Developments in SMILE: Higher Degree of Myopia and Hyperopia.

Authors:  Yan Wang; Jiaonan Ma
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019 Sep-Oct
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.